🇺🇸 FDA

Intelligence · Patent portfolio

Dyne Therapeutics Patents

Full USPTO pharma patent portfolio for Dyne Therapeutics — grant dates, expiration, and drug cross-links.

Patents
82
Expiring ≤24m
3

Quick answer

Dyne Therapeutics has 82 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 2

  1. US 11518816

    Methods of delivering an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy

    Expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11497815

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11390682

    Methods of intravenouisly delivering anti-transferrin antibody/oligonucleotide complexes to subjects having muscular dystrophy

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11369689

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11352316

    Opioid receptor modulators and products and methods related thereto

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11286305

    Complex comprising anti-transferrin receptor antibody covalently linked to an oligonucleotide that targets DUX4 RNA

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11248056

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11168141

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11129864

    Method for obtaining a plant extract and associated compositions

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11118169

    Compositions for increasing polypeptide stability and activity, and related methods

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11111309

    Method of reducing expression of DUX4 in a muscle cell by administering an anti-transferrin receptor antibody linked to an oligonucleotide targeting DUX4

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10933086

    Composition for preventing, alleviating, or treating arthritis or osteoporosis, containing neoagarooligosaccharide

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10596216

    Use of a Withania extract for the treatment of amyloid-related diseases

    Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10596217

    Compositions containing a Withania somnifera extract incubated with a filamentous fungus of the Beauvaria genus

    Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10548916

    Composition comprising neoagarooligosaccharide as active ingredient, for prevention or treatment of sepsis or septic shock

    Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9999647

    Method for obtaining a plant extract and associated compositions

    Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9816078

    Compositions for increasing polypeptide stability and activity, and related methods

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9321999

    Compositions for increasing polypeptide stability and activity, and related methods

    Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9279366

    Steam powered engine

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8716320

    Antibacteriall heterocyclic ureas

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8007853

    Vitamin/mineral composition with DHA

    Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7994217

    Prenatal multivitamin/multimineral supplement

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7811297

    Actuable structures and methods of fabrication and use

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7777027

    Purified beta glucan composition

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7704542

    Vitamin/mineral compositions with DHA

    Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7550584

    Methods of purifying beta glucans

    Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7361476

    Methionyl tRNA synthetase polynucleotides

    Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7335499

    tRNA synthetase

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7220757

    Compositions and methods for topical administration of 2-NH-heteroarylimidazoles

    Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7018986

    Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption

    Expires Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6989255

    Methionyl tRNA synthetase polypeptides from Staphylococcus aureus

    Expires Mon Jan 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6943175

    2-NH-heteroarylimidazoles with antibacterial activity

    Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6903204

    Polynucleotides encoding methionyl tRNA synthetase from Staphylococcus aureus, related products and methods

    Expires Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6162787

    Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions

    Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Dyne Therapeutics have?

82 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Dyne Therapeutics patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.